In the present study, we describe the development of a multiplexed, SNaPshot primer extension genotyping assay, which allows the rapid and cost-effective detection of targeted BRCA1 and BRCA2 mutations from breast and ovarian cancer patients in Chinese populations. This evidence concerns the gene BRCA2 and ovarian carcinoma.